Health Sciences Acquisitions 2 Receivables

The latest receivables for HSAQ is $51K as of June 2026. That compares with $83K in the prior-year period — down 38.6% year over year. Investors often review this figure alongside Health Sciences Acquisitions 2's historical trend and sector peers before judging valuation or financial health.

Over the past year, HSAQ's receivables moved from $83K to $51K — a 38.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Health Sciences Acquisitions 2's operating scale or balance-sheet position.

A receivables figure of $51K for HSAQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HSAQ's receivables ($51K), review year-over-year change from $83K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.